Kaplan A, Fischer D, Achord D, Sly W
J Clin Invest. 1977 Nov;60(5):1088-93. doi: 10.1172/JCI108860.
We recently presented data showing that mannose-6-phosphate was a potent competitive inhibitor of pinocytosis of human platelet beta-glucuronidase, and that treatment of "high-uptake" forms of the enzyme with alkaline phosphatase destroyed the high-uptake property of the enzyme without diminishing its catalytic activity. These data indicate that phosphate is a necessary component of the recognition marker on the enzyme for pinocytosis by human fibroblasts, and suggest that the phosphate on high-uptake forms of the enzyme is present as a phosphohexosyl moiety. Results presented here show that mannose-6-phosphate is also a potent inhibitor of pinocytosis of the following enzyme preparations: (a) beta-glucuronidase from human spleen, liver, placenta, and urine; (b) beta-hexosaminidase and beta-galactosidase from human platelets; (c) beta-hexosaminidase from human fibroblast secretions. Alkaline phosphatase treatment of all these enzymes except beta-galactosidase, which was unstable to the incubation conditions and could not be tested, greatly diminished the uptake activity of the enzymes without diminishing their catalytic activity. These results suggest that phosphohexosyl recognition is a general characteristic of pinocytosis of lysosomal glycosidases.
我们最近公布的数据表明,6-磷酸甘露糖是人类血小板β-葡萄糖醛酸酶胞饮作用的一种强效竞争性抑制剂,并且用碱性磷酸酶处理该酶的“高摄取”形式会破坏该酶的高摄取特性,而不会降低其催化活性。这些数据表明,磷酸是人类成纤维细胞对该酶进行胞饮作用时识别标记的必要组成部分,并表明该酶高摄取形式上的磷酸以磷酸己糖基部分的形式存在。此处给出的结果表明,6-磷酸甘露糖也是以下酶制剂胞饮作用的强效抑制剂:(a) 来自人类脾脏、肝脏、胎盘和尿液的β-葡萄糖醛酸酶;(b) 来自人类血小板的β-己糖胺酶和β-半乳糖苷酶;(c) 来自人类成纤维细胞分泌物的β-己糖胺酶。除β-半乳糖苷酶(因其对孵育条件不稳定而无法测试)外,对所有这些酶进行碱性磷酸酶处理都会大大降低酶的摄取活性,而不会降低其催化活性。这些结果表明,磷酸己糖基识别是溶酶体糖苷酶胞饮作用的一个普遍特征。